Key facts
- This page summarizes Santhosh Nagaraj's Form 4 filing for Orgenesis Inc. (ORGS).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2024, 14:42.
Santhosh Nagaraj - 12 Dec 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)
- Reporting relationship
- Director
- Issuer ticker
- ORGS
- Reported as of
- 12 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2024, 14:42:26 UTC
- Prior SEC filing
- 12 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nagaraj Santhosh
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Santhosh Nagaraj filed Form 4 for Orgenesis Inc. (ORGS) on 16 Dec 2024.
Change
- Previous filing in this sequence was filed on 12 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ORGS
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +625
- Change %
- Price
- $0.000000
- Shares after
- 625
- Date
- 12 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 625
- Exercise price
- $0.9800
- Footnotes
- F1
ORGS
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +1,250
- Change %
- Price
- $0.000000
- Shares after
- 1,250
- Date
- 12 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $0.9800
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in three years from the date of the grant, one third beginning on December 12, 2025, one third on December 12, 2026, and one third on December 12, 2027, subject to the non-employee director's continued service on the Board of Directors.
Footnote F2
These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in one year from the date of the grant, beginning on December 12, 2024, subject to the non-employee director's continued service on the Board of Directors.